$PLX Protalix BioTherapeutics, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Protalix BioTherapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Protalix BioTherapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Protalix BioTherapeutics, Inc. for free.
IRS Number: 650643773
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: PLX
Company Address: 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK 07601
Former name: EMBASSY ACQUISITION CORP, date of change: 1996-01-24
Former name: ORTHODONTIX INC, date of change: 1998-04-22
Market Capitalization: $78.10M
Prev close: $0.79
Average Daily Volume: 2,890,240
Days Low: $0.78
Year Low: $0.26
Year High: $0.96
Protalix BioTherapeutics, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 13 2020 | PLX | Protalix BioTherap ... | Rubin Eyal | Sr. VP and CFO | Grant | A | 0.00 | 246,146 | 0 | 246,146 | 0 to 246.1 K |
| Aug 13 2020 | PLX | Protalix BioTherap ... | Bashan Dror | President and CEO | Grant | A | 0.00 | 447,927 | 0 | 447,927 | 0 to 447.9 K |
| Aug 13 2020 | PLX | Protalix BioTherap ... | Naos Yaron | Sr. VP, Operations | Option Exercise | A | 3.59 | 122,656 | 440,335 | 122,656 | |
| Jul 08 2020 | PLX | Protalix BioTherap ... | Hayon Yael | VP, Research & Deve ... | Option Exercise | A | 3.73 | 129,771 | 484,046 | 129,771 | |
| Jun 08 2020 | PLX | Protalix BioTherap ... | Almon Einat Brill | SVP, Chief Developm ... | Option Exercise | A | 3.59 | 196,995 | 707,212 | 196,995 | |
| Apr 13 2020 | PLX | Protalix BioTherap ... | Schwartz Aharon | Director | Buy | P | 2.43 | 64,000 | 155,264 | 64,000 | 0 to 64 K |
| Feb 05 2020 | PLX | Protalix BioTherap ... | Bronfeld Zeev | Director | Option Exercise | A | 3.70 | 240,000 | 888,000 | 240,000 | |
| Jan 22 2020 | PLX | Protalix BioTherap ... | Granot David | Director | Option Exercise | A | 3.55 | 40,000 | 142,000 | 40,000 | |
| Jan 22 2020 | PLX | Protalix BioTherap ... | Bar-Shalev Amos | Director | Option Exercise | A | 3.55 | 40,000 | 142,000 | 40,000 | |
| Jan 22 2020 | PLX | Protalix BioTherap ... | Schwartz Aharon | Director | Option Exercise | A | 3.55 | 40,000 | 142,000 | 40,000 | |
| Jan 22 2020 | PLX | Protalix BioTherap ... | Boudes Pol F | Director | Option Exercise | A | 3.55 | 40,000 | 142,000 | 40,000 | |
| Jan 22 2020 | PLX | Protalix BioTherap ... | Melincoff Gwen A | Director | Option Exercise | A | 3.55 | 40,000 | 142,000 | 40,000 | |
| Sep 24 2019 | PLX | Protalix BioTherap ... | Rubin Eyal | Sr. VP & CFO | Option Exercise | A | 0.20 | 800,000 | 160,000 | 800,000 | |
| Jul 02 2019 | PLX | Protalix BioTherap ... | Bashan Dror | President & CEO | Option Exercise | A | 0.47 | 1,600,000 | 750,400 | 1,600,000 | |
| Sep 14 2018 | PLX | Protalix BioTherap ... | Maimon Yossi | VP, Chief Financial ... | Option Exercise | A | 0.56 | 700,000 | 392,000 | 700,000 |
View all Protalix BioTherapeutics, Inc. insider transactions.